About this project
Our previously published data have demonstrated significantly increased antibody response towards milk, egg and gluten proteins in children with CP, compared with matched controls, with underweighted individuals having a higher antibody response. Abnormal immune response to gluten is closely associated with celiac disease (CD), but the immune response in this group is distinct from CD. The specific antibody response to gluten proteins can differs in extra- intestinal gluten related disorders that are not celiac disease. If a specific antibody response is seen, in this group of children, it would indicate the possibility of gluten free treatment.
We also plan to investigate whether these antibodies found previously in our studies, are associated with marker of blood-brain barrier disruption and neural injury. If an association is shown, it would provide an impetus for examining the effect of gluten-free diet in a subset of patients with the antibody response. This group of patients could then benefit from gluten free diet (GFD) both in terms of under nutrition and brain/neurological symptoms.
To have serological brain injury markers early in life, that may indicate which sub-diagnosis of CP a child is likely have, would be extremely helpful for the child, parents and in clinical practice. You can then make a possible prognosis of the child’s future, since it differs between the subtypes. It is also very important for the clinician to know which CP-subtype the child belongs to, in order to give an optimal medical care.
To characterize the molecular specificity of the antibody response to gluten, in order to find a subgroup of patients that could benefit from gluten free diet (GFD), using Western blotting.
Asst.Prof Armin Alaedini and Prof. Peter Green
Celiac Disease Center, Columbia University, New York.